SCHEMBL10094367

SCHEMBL10094367

CC(C)c1cn(Cc2ccc(C(C)(C)C)cc2)nn1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 7/20 0.57
HSP90AB1 P08238 7/20 0.57
HDAC1 Q13547 1/20 0.47
MGAM O43451 2/20 0.44
GAA P10253 2/20 0.44
SI P14410 2/20 0.44
MGAM2 Q2M2H8 2/20 0.44
PSEN1 P49768 1/20 0.41
PSEN2 P49810 1/20 0.41
KCNH2 Q12809 1/20 0.41
APH1B Q8WW43 1/20 0.41
NCSTN Q92542 1/20 0.41
APH1A Q96BI3 1/20 0.41
PSENEN Q9NZ42 1/20 0.41
ESRRG P62508 1/20 0.40
EGLN1 Q9GZT9 1/20 0.40
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
EPHB4 P54760 1/20 0.38
TEK Q02763 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18925230 0.83 NOTUM (0.55) HDAC1ESRRGNPC1RAB9AMEN1
SCHEMBL12229080 0.81 CYP19A1 (0.56) NPC1RAB9A
SCHEMBL12194478 0.80 MEN1 (0.56) HSP90AA1HSP90AB1HDAC1NPC1RAB9A
SCHEMBL23318237 0.80 ESRRG (0.40) ESRRGNPC1RAB9AEPHB4TEK
SCHEMBL10094376 0.79 HSP90AB1 (0.57) HSP90AB1HDAC1ESRRGNPC1RAB9A
SCHEMBL23386948 0.78 CYP19A1 (0.60) HDAC1
SCHEMBL2819423 0.76 NOTUM (0.68) HSP90AA1HSP90AB1HDAC1MGAMGAA
SCHEMBL2819878 0.75 TEK (0.49) HSP90AA1HSP90AB1HDAC1EGLN1EPHB4
SCHEMBL10094377 0.75 HSP90AB1 (0.62) HSP90AB1HDAC1GAAEGLN1NPC1
SCHEMBL10094370 0.75 SIGMAR1 (0.50) HSP90AB1ESRRGMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8148535-B2 Potassium channel inhibitors MERCK SHARP & DOHME CORP. (US) 2012-04-03 US disclosed
US-20090233897-A1 Potassium Channel Inhibitors MERCK SHARP & DOHME CORP. 2009-09-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090233897-A1 Potassium Channel Inhibitors KCNJ2, KCNQ2, KCNH2 HSP90AA1 3850/4885HSP90AB1 3191/4885HDAC1 993/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.